Page 10 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated Jul 24, 2021 | 07:01 IST All India Institute of Medical Sciences chief Dr Randeep Guleria said that the Covid-19 booster dose will be a second-generation vaccine. Representational Image.  |  Photo Credit: PTI Key Highlights The AIIMS director informed that Bharat Biotech’s Covaxin trials for children are currently underway and results could be out by September The trials are being conducted in three phases – the first was started in the age group of 12-18 years, followed by 6-12 years and 2-6 years New Delhi: With the SARS-CoV-2 virus mutating rapidly into various different strains in just over a year since the Covid-19 outbreak, the emerging threat would be to devise a vaccine that could combat these new variants who seem to be showing resistance to some vaccines.

New delhiZydus cadilaRandeep guleriaIndia institute of medical sciencesPhoto creditBharat biotechAll india instituteMedical sciencesHyderabad based bharat biotechபுதியது டெல்ஹிஜய்துச் காடிலாரந்தீப் குலேரியாஇந்தியா நிறுவனம் ஆஃப் மருத்துவ அறிவியல்புகைப்படம் கடன்பாரத் பயோடெக்அனைத்தும் இந்தியா நிறுவனம்